OpenVSafe by OpenVAERS
Search V-safe

7HN-11814-95239

4 vaccinations 6 coded responses 49 check-ins 5 free-text entries 0 call cases
Sex
Male
Age at first dose
56-60
ZIP prefix
274 / NC
Registered
2021-03-21
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-18
    Dose 1 — Pfizer-BioNTech
  2. 2021-03-21
    Registered in v-safe
  3. 2021-03-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-03-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2021-03-23
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-03-24
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-03-25
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-04-01
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  9. 2021-04-08
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  10. 2021-04-12
    Dose 2 — Pfizer-BioNTech
  11. 2021-04-12
    Health check-in — day 0, dose 2
    Feeling: Good · None
    Adult check-in
  12. 2021-04-13
    Survey response — days 1–6 daily, dose 2
    MedDRA: Injection site discomfort — Feeling: Fair · Site: Pain · Muscle or body aches · Be unable to do your normal daily activities
    Free text: Marked discomfort in injection site shoulder
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-04-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · None
    Adult check-in
  14. 2021-04-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  15. 2021-04-16
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  16. 2021-04-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-04-18
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-04-19
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-04-26
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-05-03
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-05-10
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-05-17
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-05-24
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-07-12
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-10-11
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-12-20
    Dose 3 — Pfizer-BioNTech
    Co-administered: Flu
  27. 2021-12-23
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  28. 2021-12-24
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  29. 2021-12-25
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  30. 2021-12-26
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · None
    Adult check-in
  31. 2021-12-27
    Health check-in — day 7, dose 3
    Feeling: Good · Headache
    Adult check-in
  32. 2022-01-03
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  33. 2022-01-10
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  34. 2022-01-17
    Survey response — day 28, dose 3
    MedDRA: Pain, Pre-existing disease — Feeling: Poor · Be unable to do your normal daily activities
    Free text: Significant worsening of CHRONIC knee & lower leg pain, and gradually worsening rotator cuff & deltoid area pain -- note that this is in OPPOSITE arm of both covid & flu injections, and each began prior to receiving them.
    MedDRA releases: 2024-11 · check-in free text available
  35. 2022-01-24
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  36. 2022-01-31
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  37. 2022-03-21
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  38. 2022-06-20
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  39. 2022-07-27
    Dose 4 — Pfizer-BioNTech
  40. 2022-07-27
    Health check-in — day 0, dose 4
    Feeling: Good · None
    Adult check-in
  41. 2022-07-28
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  42. 2022-07-29
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  43. 2022-07-30
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  44. 2022-07-31
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  45. 2022-08-01
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  46. 2022-08-02
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  47. 2022-08-03
    Health check-in — day 7, dose 4
    Feeling: Good · None
    Adult check-in
  48. 2022-08-10
    Survey response — day 14, dose 4
    MedDRA: Condition aggravated, Fatigue, Headache, Poor quality sleep, Pre-existing disease — Feeling: Good · Be unable to do your normal daily activities
    Free text: Persistent frontal headache (3 days); more easily fatigued than usual (2 days); & poor sleep (exacerbation of preexisting restless leg syndrome)
    MedDRA releases: 2024-11 · check-in free text available
  49. 2022-08-17
    Health check-in — day 21, dose 4
    Feeling: Good
    Adult check-in
  50. 2022-08-24
    Health check-in — day 28, dose 4
    Feeling: Good
    Adult check-in
  51. 2022-08-31
    Survey response — day 35, dose 4
    MedDRA: Blood pressure diastolic increased, Blood pressure systolic increased, Headache — Feeling: Fair
    Free text: Unexplained and significant elevation of systolic & diastolic BP x3 days with headache
    MedDRA releases: 2024-11 · check-in free text available
  52. 2022-09-08
    Health check-in — day 42, dose 4
    Feeling: Good
    Adult check-in
  53. 2022-10-26
    Survey response — 3 months, dose 4
    MedDRA: Asthenia, Condition aggravated, Disturbance in attention, Fatigue, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activities
    Free text: More easily fatigued & m7ch less stamina x few weeks; hard(er) to stay on task & concentrate than baseline (have significant ADHD)
    MedDRA releases: 2024-11 · check-in free text available
  54. 2023-01-27
    Survey response — 6 months, dose 4
    MedDRA: Abdominal pain upper, Cough, Malaise, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activities
    MedDRA releases: 2024-11

Vaccinations

DoseDateManufacturerCo-administered
12021-03-18Pfizer-BioNTech
22021-04-12Pfizer-BioNTech
32021-12-20Pfizer-BioNTech Flu
42022-07-27Pfizer-BioNTech No

Free text

Release 7 — days 1–6 daily, dose 2

2021-04-13

Systemic reaction (other): Marked discomfort in injection site shoulder

Release 10 — day 28, dose 3

2022-01-17

Symptoms: Significant worsening of CHRONIC knee & lower leg pain, and gradually worsening rotator cuff & deltoid area pain -- note that this is in OPPOSITE arm of both covid & flu injections, and each began prior to receiving them.

Release 12 — day 14, dose 4

2022-08-10

Symptoms: Persistent frontal headache (3 days); more easily fatigued than usual (2 days); & poor sleep (exacerbation of preexisting restless leg syndrome)

Release 12 — day 35, dose 4

2022-08-31

Symptoms: Unexplained and significant elevation of systolic & diastolic BP x3 days with headache

Release 12 — 3 months, dose 4

2022-10-26

Symptoms: More easily fatigued & m7ch less stamina x few weeks; hard(er) to stay on task & concentrate than baseline (have significant ADHD)

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAbdominal pain upper · · ✓
SDAsthenia · · ✓
SDBlood pressure diastolic increased · · ✓
SDBlood pressure systolic increased · · ✓
SDCondition aggravated · · ✓
SDCough · · ✓
SDDisturbance in attention · · ✓
SDFatigue · · ✓
SDHeadache · · ✓
SDMalaise · · ✓
SDPain · · ✓
SDPoor quality sleep · · ✓
SDPre-existing disease · · ✓
SROInjection site discomfort ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release